The novel approach of this peptide represents a exciting advance in the handling of diabetes mellitus type 2. Different to existing medications, tirzepatide affects dual pathways – glucagon-like peptide-1 (GLP-1) and https://tirzepatidepeptide471928.bligblogging.com/42741113/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment